- Home
- OTLK vs FKWL Comparison
OTLK vs FKWL Comparison
Compare OTLK & FKWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OTLK
- FKWL
- Stock Information
- Founded
- OTLK 2010
- FKWL 1981
- Country
- OTLK United States
- FKWL United States
- Employees
- OTLK N/A
- FKWL N/A
- Industry
- OTLK Biotechnology: Biological Products (No Diagnostic Substances)
- FKWL Telecommunications Equipment
- Sector
- OTLK Health Care
- FKWL Utilities
- Exchange
- OTLK Nasdaq
- FKWL Nasdaq
- Market Cap
- OTLK 42.8M
- FKWL 45.8M
- IPO Year
- OTLK 2016
- FKWL 1996
- Fundamental
- Price
- OTLK $1.46
- FKWL $5.05
- Analyst Decision
- OTLK Buy
- FKWL Strong Buy
- Analyst Count
- OTLK 5
- FKWL 1
- Target Price
- OTLK $5.25
- FKWL $6.00
- AVG Volume (30 Days)
- OTLK 2.5M
- FKWL 28.4K
- Earning Date
- OTLK 08-14-2025
- FKWL 11-13-2025
- Dividend Yield
- OTLK N/A
- FKWL N/A
- EPS Growth
- OTLK N/A
- FKWL N/A
- EPS
- OTLK N/A
- FKWL N/A
- Revenue
- OTLK $1,505,322.00
- FKWL $46,086,901.00
- Revenue This Year
- OTLK N/A
- FKWL N/A
- Revenue Next Year
- OTLK $313.69
- FKWL N/A
- P/E Ratio
- OTLK N/A
- FKWL N/A
- Revenue Growth
- OTLK N/A
- FKWL 49.65
- 52 Week Low
- OTLK $0.79
- FKWL $3.67
- 52 Week High
- OTLK $6.98
- FKWL $7.45
- Technical
- Relative Strength Index (RSI)
- OTLK 62.88
- FKWL 81.29
- Support Level
- OTLK $1.18
- FKWL $4.10
- Resistance Level
- OTLK $1.30
- FKWL $4.60
- Average True Range (ATR)
- OTLK 0.10
- FKWL 0.21
- MACD
- OTLK 0.07
- FKWL 0.08
- Stochastic Oscillator
- OTLK 83.63
- FKWL 95.50
About OTLK Outlook Therapeutics Inc.
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.
About FKWL Franklin Wireless Corp.
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.